OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2025
(4)
2022
(4)
2024
(3)
2023
(3)
2021
(2)
2020
(1)
2007
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Bim mediates mitochondria-regulated particulate matter-induced apoptosis in alveolar epithelial cells.
Not available
S-EPMC2140150
|
biostudies-literature
Cite
Opioid Use After Knee Arthroscopy.
Not available
S-EPMC7190545
|
biostudies-literature
Cite
Association of Job Characteristics and Functional Impairments on Return to Work After ARDS.
Not available
S-EPMC8411444
|
biostudies-literature
Cite
Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens.
Not available
S-EPMC10945603
|
biostudies-literature
Cite
Generation of a Double Reporter mES Cell Line to Simultaneously Trace the Generation of Retinal Progenitors and Photoreceptors.
Not available
S-EPMC11854395
|
biostudies-literature
Cite
PD-1 defines a distinct, functional, tissue-adapted state in Vδ1<sup>+</sup> T cells with implications for cancer immunotherapy.
Not available
S-EPMC10965442
|
biostudies-literature
Cite
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Not available
S-EPMC10320213
|
biostudies-literature
Cite
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Not available
S-EPMC9932578
|
biostudies-literature
Cite
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Not available
S-EPMC11333271
|
biostudies-literature
Cite
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis.
Not available
S-EPMC12848353
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets